ERK/MAPK Signaling Is Essential for Intestinal Development through Wnt Pathway Modulation

Scientists found that deletion of Erk1/2 in intestinal epithelial cells at embryonic stages resulted in an unexpected increase in cell proliferation and migration, expansion of intestinal stem cells and formation of polyp-like structures, leading to postnatal death.
[Development]
ERK/MAPK signaling is essential for intestinal development through Wnt pathway modulation | Development. (n.d.). Retrieved August 7, 2020, from https://dev.biologists.org/content/early/2020/07/30/dev.185678 Cite
Abstract

Continue reading “ERK/MAPK Signaling Is Essential for Intestinal Development through Wnt Pathway Modulation”

Bookmark

No account yet? Register

0
Share

Downregulation of STK4 Promotes Colon Cancer Invasion/Migration through Blocking β‐Catenin Degradation

Researchers found that STK4 knockdown enhanced sphere formation and metastasis in vitro and promoted tumor development in vivo. STK4 colocalized with β‐catenin and directly phosphorylated β‐catenin resulting to its degradation via the ubiquitin‐mediated pathway.
[Molecular Oncology]
Lin, C.-H., Hsu, T.-I., Chiou, P.-Y., Hsiao, M., Wang, W.-C., Chen, Y.-C., Lin, J.-T., Wang, J.-Y., Lin, P.-C., Lin, F.-C., Tseng, Y.-K., Cheng, H.-C., Chen, C.-L., & Lu, P.-J. (n.d.). Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradation. Molecular Oncology, n/a(n/a). https://doi.org/10.1002/1878-0261.12771 Cite
Abstract

Continue reading “Downregulation of STK4 Promotes Colon Cancer Invasion/Migration through Blocking β‐Catenin Degradation”

Bookmark

No account yet? Register

0
Share

Novel Long Noncoding RNAs Upregulation May Have Synergistic Effects on the CYP24A1 and PFDN4 Biomarker Role in Human Colorectal Cancer

Investigators surveyed the expression levels and clinical significance of novel long noncoding RNAs related to CYP24A1 and PFDN4 genes in colorectal cancer using real‐time polymerase chain reaction. They also assessed the expression of these genes after vitamin D treatment in HCT‐116 and HT‐29 colon cancer cell lines.
[Journal of Cellular Physiology]
Sadeghi, H., Nazemalhosseini‐Mojarad, E., Sahebi, U., Fazeli, E., Azizi‐Tabesh, G., Yassaee, V. R., Savabkar, S., Aghdaei, H. A., Zali, M. R., & Mirfakhraie, R. (n.d.). Novel long noncoding RNAs upregulation may have synergistic effects on the CYP24A1 and PFDN4 biomarker role in human colorectal cancer. Journal of Cellular Physiology, n/a(n/a). https://doi.org/10.1002/jcp.29992 Cite
Abstract

Continue reading “Novel Long Noncoding RNAs Upregulation May Have Synergistic Effects on the CYP24A1 and PFDN4 Biomarker Role in Human Colorectal Cancer”

Bookmark

No account yet? Register

0
Share

Berberine Inhibits Intestinal Epithelial Barrier Dysfunction in Colon Caused by Peritoneal Dialysis Fluid by Improving Cell Migration

In the wound healing assay, berberine exhibited the ability to promote cell migration, indicating that berberine could probably recover the function of intestinal epithelial cells when the intestinal epithelial barrier was damaged by the peritoneal dialysis fluid.
[Journal of Ethnopharmacology]
Zhang, D., Jiang, L., Wang, M., Jin, M., Zhang, X., Liu, D., Wang, Z., Yang, L., & Xu, X. (2020). Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration. Journal of Ethnopharmacology, 113206. https://doi.org/10.1016/j.jep.2020.113206 Cite
AbstractGraphical Abstract

Continue reading “Berberine Inhibits Intestinal Epithelial Barrier Dysfunction in Colon Caused by Peritoneal Dialysis Fluid by Improving Cell Migration”

Bookmark

No account yet? Register

0
Share

Correction of CFTR Function in Intestinal Organoids to Guide Treatment of Cystic Fibrosis

Intestinal organoids were grown from rectal biopsies in a cohort of 97 subjects with cystic fibrosis. Residual CFTR function was measured by quantifying organoid swelling induced by forskolin and response to modulators by quantifying organoid swelling induced by CFTR correctors, potentiator and their combination.
[European Respiratory Journal]
Ramalho, A. S., Fürstová, E., Vonk, A. M., Ferrante, M., Verfaillie, C., Dupont, L., Boon, M., Proesmans, M., Beekman, J. M., Sarouk, I., Cordero, C. V., Vermeulen, F., & Boeck, K. D. (2020). Correction of CFTR function in intestinal organoids to guide treatment of Cystic Fibrosis. European Respiratory Journal. https://doi.org/10.1183/13993003.02426-2019 Cite
Abstract

Continue reading “Correction of CFTR Function in Intestinal Organoids to Guide Treatment of Cystic Fibrosis”

Bookmark

No account yet? Register

0
Share

Dihydroxystilbenes Prevent Azoxymethane/Dextran Sulfate Sodium-Induced Colon Cancer by Inhibiting Colon Cytokines, a Chemokine, and Programmed Cell Death-1 in C57BL/6J Mice

The three dihydroxystilbenes in this study inhibited colon carcinogenesis and tumor growth as well as increases in colon IL-1β, IL-6, MCP-1, and PD-1 levels in AOM/DDS-treated mice in vivo. The three dihydroxystilbenes also suppressed COX-2 expression in colon tumors in vivo and inhibited PD-1 elevations in M2-THP-1 macrophages in vitro.
[European Journal of Pharmacology]
Kimura, Y., Sumiyoshi, M., Kiyoi, T., & Baba, K. (2020). Dihydroxystilbenes prevent azoxymethane/dextran sulfate sodium-induced colon cancer by inhibiting colon cytokines, a chemokine, and programmed cell death-1 in C57BL/6J mice. European Journal of Pharmacology, 173445. https://doi.org/10.1016/j.ejphar.2020.173445 Cite
Abstract

Continue reading “Dihydroxystilbenes Prevent Azoxymethane/Dextran Sulfate Sodium-Induced Colon Cancer by Inhibiting Colon Cytokines, a Chemokine, and Programmed Cell Death-1 in C57BL/6J Mice”

Bookmark

No account yet? Register

0
Share

Intestinal TLR9 Deficiency Exacerbates Hepatic IR Injury via Altered Intestinal Inflammation and Short‐Chain Fatty Acid Synthesis

Mice lacking intestinal TLR9 had profoundly increased liver injury after hepatic ischemia reperfusion(IR) compared to WT mice with exacerbated hepatocyte necrosis, apoptosis, neutrophil infiltration, and inflammatory cytokine generation. They also observed increased small intestinal inflammation and apoptosis after hepatic IR in intestinal TLR9 deficient mice. Fecal short‐chain fatty acids butyrate and propionate levels were lower in intestinal TLR9 deficient mice.
[FASEB Journal]
Han, S. J., Kim, M., Novitsky, E., D’Agati, V., & Lee, H. T. (n.d.). Intestinal TLR9 deficiency exacerbates hepatic IR injury via altered intestinal inflammation and short-chain fatty acid synthesis. The FASEB Journal, n/a(n/a). https://doi.org/10.1096/fj.202000314R Cite
Full Article

Continue reading “Intestinal TLR9 Deficiency Exacerbates Hepatic IR Injury via Altered Intestinal Inflammation and Short‐Chain Fatty Acid Synthesis”

Bookmark

No account yet? Register

0
Share

Long Non-Coding RNA MIR503HG Inhibits the Proliferation, Migration and Invasion of Colon Cancer Cells via MiR-107/Par4 Axis

MIR503HG negatively regulated its target miR-107. MiR-107 overexpression reversed the anti-tumor effects of MIR503HG overexpression on colon cancer cells. Par4 was a target of miR-107, which was positively regulated by MIR503HG. The promoting effects of MIR503HG silencing on colon cancer cells were eliminated by Par4 overexpression.
[Experimental Cell Research]
Han, H., Li, H., & Zhou, J. (2020). Long non-coding RNA MIR503HG inhibits the proliferation, migration and invasion of colon cancer cells via miR-107/Par4 axis. Experimental Cell Research, 395(2), 112205. https://doi.org/10.1016/j.yexcr.2020.112205 Cite
Abstract

Continue reading “Long Non-Coding RNA MIR503HG Inhibits the Proliferation, Migration and Invasion of Colon Cancer Cells via MiR-107/Par4 Axis”

Bookmark

No account yet? Register

0
Share

Rock Inhibition Promotes Nav1.5 Sodium Channel-Dependent SW620 Colon Cancer Cell Invasiveness

Y-27632 induced the acquisition of a pro-migratory cell phenotype and increased cancer cell invasiveness in both 3- and 2-dimensions assays. This effect was prevented by the inhibition of NaV1.5 voltage-gated sodium channel activity. ROCK inhibition enhanced the activity of the pro-invasive NaV1.5 channel through a pathway that was independent of gene expression regulation.
[Scientific Reports]
Poisson, L., Lopez-Charcas, O., Chadet, S., Bon, E., Lemoine, R., Brisson, L., Ouaissi, M., Baron, C., Besson, P., Roger, S., & Moussata, D. (2020). Rock inhibition promotes Na V 1.5 sodium channel-dependent SW620 colon cancer cell invasiveness. Scientific Reports, 10(1), 13350. https://doi.org/10.1038/s41598-020-70378-3 Cite
Full Article

Continue reading “Rock Inhibition Promotes Nav1.5 Sodium Channel-Dependent SW620 Colon Cancer Cell Invasiveness”

Bookmark

No account yet? Register

0
Share

Hallmarks of Intestinal Stem Cells

The authors summarise the recent findings into how intestinal stem cell(ISC) identity can be defined by proliferation state, signalling crosstalk, epigenetics and metabolism, and propose an update on the hallmarks of ISCs. We further discuss how these properties contribute to intestinal development and the dynamics of injury-induced regeneration.
[Development]
Hallmarks of intestinal stem cells | Development. (n.d.). Retrieved August 7, 2020, from https://dev.biologists.org/content/147/15/dev182675.long Cite
Full Article

Continue reading “Hallmarks of Intestinal Stem Cells”

Bookmark

No account yet? Register

0
Share

European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis

Celltrion Healthcare announced that the European Commission has granted marketing authorisation for Remsima® subcutaneous formulation for the treatment of adult patients with ankylosing spondylitis, Crohn’s disease, ulcerative colitis, psoriatic arthritis and psoriasis.
[Celltrion]
Press Release

Continue reading “European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis”

Bookmark

No account yet? Register

0
Share

Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China

Hutchison China MediTech Limited and Eli Lilly and Company announced an amendment to the 2013 License and Collaboration Agreement on Fruquintinib with Lilly Shanghai, an affiliate of Lilly. The 2020 Amendment covers the expansion of Chi-Med’s role in the commercialization of Elunate® in China.
[Hutchison China MediTech Limited]
Press Release

Continue reading “Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China”

Bookmark

No account yet? Register

0
Share
Share